Wellington Management Company »

Bridgebio Pharma shares owned by Wellington Management Company

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 8.1M 1.70

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Wells Fargo & Company (WFC)
Johnson & Johnson (JNJ)
Astrazeneca Ord (AZN)
Sempra Energy (SRE)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wellington Management Company

Top funds holding Bridgebio Pharma

Linden Advisors
D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
Jump Financial
CSS
Alberta Investment Management Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Wellington Management Company
Calamos Advisors
Susquehanna Advisors Group
State Street Corporation

View all funds holding Bridgebio Pharma